229 patents
Utility
Neoadjuvant Chemotherapy Induces Breast Cancer Metastasis Through a Tmem-mediated Mechanism
18 Jan 24
Methods of reducing chemotherapy-induced metastasis, or chemotherapy-induced cancer cell dissemination, for patients subject to chemotherapy using Tie-2 inhibitors.
John S. Condeelis, Maja Oktay
Filed: 13 Sep 23
Utility
High Resolution Intravital Imaging and Uses Thereof
4 Jan 24
Methods and apparatus are provided for high resolution intravital imaging and for chronic optical imaging of tissues such as lung.
David Entenberg, John S. Condeelis, Sonia E. Voiculescu
Filed: 21 Jun 23
Utility
t2u8rupuohylsgqukm97v4spnt13dglvx9y12lm4do8smophhdcz05vl2m
4 Jan 24
Methods of predicting response of a subject in need of immunosuppressant therapy to a Cluster of differentiation 40 (CD40)-targeted treatment are disclosed.
Yaron Tomer, Larissa C. Faustino, George J. Kahaly
Filed: 2 Dec 21
Utility
yidr3ubbauwpn4pp4rm65rqbi ehal8nmveq8725
28 Dec 23
Microvesicles produced by stem cells grown on a silk scaffold for enhancing stem cell self-renewal/proliferation and promoting tenogenesis in damaged tendons, and their use in tendon wound repair and tendinopathy treatment.
Hui B. Sun
Filed: 3 Mar 23
Utility
hbfgo94g9phqadnjnu1k2l1kk9bcc
7 Dec 23
A reporter mycobacteriophage comprising a heterologous nucleic acid comprising a promoter-reporter construct encoding a promotor operably linked to a nucleotide sequence encoding a fusion protein, wherein the fusion protein comprises a luciferase protein linked to a fluorescent protein.
William R. Jacobs, Saranathan Rajagopalan, Emmanuel Asare
Filed: 1 Nov 21
Utility
g4d07ggjcllsdfxa1x29h
5 Dec 23
Ana Maria Cuervo, Evripidis Gavathiotis
Filed: 30 Aug 18
Utility
vykzcq368nuszofng81ivrhhzgkq3xagwqfgroimp v2j
5 Dec 23
Persistence and linking of analytic products is provided.
Parsa Mirhaji, Jannes Aasman
Filed: 14 Jul 17
Utility
oh2qgpsl7ac3qfwall1waudtbiv8pyuds1 1zdxn5js52x0lc4kl
23 Nov 23
A pharmaceutical combination comprising a B-cell lymphoma 2 associated X protein (BAX) activating compound an anti-apoptotic protein inhibiting compound is provided.
Evripidis Gavathiotis
Filed: 17 Sep 21
Utility
dylrz08thisafa9clwipczdu31hh8shdz0jham5
23 Nov 23
Described herein are methods of treating an individual in need of treatment or prevention of infection with a virus including administering to the individual a therapeutically effective amount of extracellular vesicles released from neural stem cells and/or neural progenitor cells, or administering to the individual a therapeutically effective amount of a composition including one or more piRNAs, wherein the piRNAs have a perfect match with a sense or antisense sequence of the genome of the virus in a primary lead sequence at positions 2-8.
Dongsheng Cai
Filed: 5 Oct 21
Utility
dqw7lekypcsx87d26o7l1vnymtdn6rpzvubxk12pu6x7vxyb
16 Nov 23
Provided are high affinity Mycobacterium tuberculosis capsule-specific antibodies and fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments.
Jacqueline M. Achkar, Jonathan Lai, Elise Ishida, Daniel Hofmann, Tingting Chen
Filed: 28 Apr 23
Utility
m50azpk2 cne9jwlelz0ucur5xuzyrfwpyy244oswb2wxiaxno11p3uf
16 Nov 23
Polypeptides, nucleic acids, and compositions thereof are provided that include a targeting moiety.
Harris GOLDSTEIN, Steven C ALMO, Scott GARFORTH, Mengyan LI
Filed: 8 Mar 21
Utility
nx2by0l9c70nacdi6i5w2rhc10csruocpjga4s7d93iomjm8q8cqtqxfxbi
14 Nov 23
Activators of mitofusins and their uses in treatment of diseases and disorders are disclosed.
Evripidis Gavathiotis, Richard N. Kitsis, Nikolaos Biris, Emmanouil Zacharioudakis
Filed: 16 Oct 18
Utility
wd7b1920cbgl86n589x2uhfevcdwu691erjm2m3 rn75a8n63or
2 Nov 23
Methods for treating or preventing diseases and conditions associated with Clostridium difficile infection are provided.
Vern L. SCHRAMM, Ashleigh S. PAPARELLA, Peter Charles TYLER
Filed: 6 May 21
Utility
ig4bkzlh6lhbj60zbtt0
31 Oct 23
Methods of reducing chemotherapy-induced metastasis, or chemotherapy-induced cancer cell dissemination, for patients subject to chemotherapy using Tie-2 inhibitors.
John S. Condeelis, Maja Oktay
Filed: 30 May 18
Utility
7554orwpsc3lj51aokuatt6rpdddcwjkt mw8vadp1bvfie
17 Oct 23
A transdermal formulation for the delivery of a nitric oxide booster or nitric oxide precursor to a subject is provided.
Joel M. Friedman
Filed: 25 Apr 23
Utility
cgx r0623w9g2aon73ool9u6els8p5
17 Oct 23
A composition and a kit comprising a nitrite source admixed with a gelling agent for nitric oxide production.
Joel M. Friedman
Filed: 19 Sep 22
Utility
2eth23bsz21tpvihfhr5vx4gzbo537gaaf2mx69w t3wn9wx7u
17 Oct 23
A device for generating nitric oxide is disclosed.
Joel M. Friedman
Filed: 30 Aug 22
Utility
94a4ieu360ae1g520i06ckcc8jf3zhhiaqoetvzx697k
10 Oct 23
An RNA tagging system for visualization of single mRNA molecules based on a MSB-MCP system, as well as methods of use.
Robert H. Singer, Evelina Tutucci, Maria Vera Ugalde
Filed: 19 Apr 18
Utility
1hd9fe49is7iuamyyasqm0vtbxb9k98i xuie61o3
28 Sep 23
Evripidis GAVATHIOTIS, Bogos AGIANIAN
Filed: 13 Aug 21
Utility
6t6 5wdasqpywem9doyjumm0uwls7knj1ybanbrbmi
21 Sep 23
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, compositions and vaccines comprising such, and methods of use thereof are each provided.
William Jacobs, JR., Betsy Herold, Joseph Dardick, Kayla A. Weiss
Filed: 29 Nov 22